CSPC Pharmaceutical Group ( ($HK:1093) ) just unveiled an announcement. CSPC Pharmaceutical Group has received marketing approval from China’s ...

CSPC Pharmaceutical Group ( ($HK:1093) ) has shared an announcement. CSPC Pharmaceutical Group announced that its subsidiary, CSPC Innovation ...

AstraZeneca has forged a wide-ranging collaboration with Chinese biotech CSPC Pharma that will focus on the use of artificial intelligence (AI) to find new medicines across a range of diseases. The ...

When Immigration and Customs Enforcement (ICE) agents arrest undocumented immigrants—there were more than 65,000 in custody ...

[RISK DISCLAIMER] All opinions, news, analysis, prices or other information contained on this report is provided by analyst of Zhejiang Huarui Information Consulting Co., Ltd (CCFGroup) as general ...

In 11 reported incidents, fire caused “three minor burn injuries and property damage totaling over $380,000,” the recall ...

AstraZeneca has joined the ranks of pharma companies seeking to bring drugs targeting lipoprotein(a) to market, paying $100 million upfront for rights to a drug developed by CSPC Pharmaceutical. The ...

The Board of Directors of CSPC Pharmaceutical Group announced it has received approval from China's National Medical Products Administration to begin clinical trials for SYH2061 Injection, an ...

Madrigal Pharmaceuticals (NASDAQ:MDGL) said it has signed a global licensing deal with CSPC Pharmaceutical (OTCPK:CSPCY) (OTCPK:CHJTF) for SYH2086, a new oral GLP-1 receptor agonist. As part of the ...

Madrigal Pharmaceuticals Inc. and CSPC Pharmaceutical Group Ltd. have entered into an exclusive global license agreement for CSPC’s SYH-2086, a preclinical oral small-molecule glucagon-like peptide-1 ...

Madrigal will study SYH2086 in combination with Rezdiffra for metabolic dysfunction-associated steatohepatitis, aiming for clinical trials in early 2026. Madrigal Pharmaceuticals is looking to China ...